Company Profile

BioProgress plc

March cambs, , United Kingdom

Pharmaceuticals Products - Trader,
Proprietorship Firm Since 1996

BioProgress Technology Ltd was founded in 1996 with the initial concept of producing materials to retire gelatin as the principal material used for the encapsulation of drugs, vitamins and other oils and powders. In 1997, BTL obtained a public listing for its shares by reversing into BioProgress Technology International, Inc (BTII).

BTII's shares were traded on the NASD OTC Bulletin Board in New York until May 2003, at which time BTII was acquired by BioProgress plc, which raised ?5 million gross through a placing with institutions at 16p and was admitted to the Alternative Investment Market of the London Stock Exchange with the symbol BPRG.

BioProgress is engaged primarily in the development and commercialisation of patents covering water soluble and biodegradable films, and process machinery. Our films and machines are marketed under the headline brand XGel?. Together they give existing products in the market a significantly enhanced level of performance, while enabling the development of new products that are not possible with other existing technologies.

BioProgress is focusing on high value applications for its technology and is developing four new oral dosage forms under the XGel? brand for the pharmaceutical and dietary supplement markets. The XGel? Film System, and its variants, can provide fast, animal-free encapsulation of drugs, vitamins and other oils and powders.

Products :
We are Suppliers of non-gelatin films for use with pharmaceuticals, vitimans and supplements. - Our Product & Services :- - XGel? Film System - NRobe system - TABWRAP? - SEPTUM? - SWOLLO - Non-Ingestible Encapsulation - Medical - Research & Development